Loading...

Purified anti-Myelin Basic Protein Antibody (Previously Covance catalog# SMI-99P)

Pricing & Availability
Clone
SMI 99 (See other available formats)
Regulatory Status
RUO
Other Names
MBP, Golli-MBP, myelin A1 protein, myelin membrane encephalitogenic protein
Previously
Covance Catalog# SMI-99P
Isotype
Mouse IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
A_SMI99_PURE_Myelin_IHCP_HuBrain20x_100418
IHC staining of purified anti-Myelin Basic Protein antibody (clone SMI 99) on formalin-fixed paraffin-embedded human brain tissue. Following antigen retrieval using Retrieve-All Antigen Unmasking System 3: Acidic, 100X (Cat. No. 927601), the tissue was incubated with 0.25 µg/ml of the primary antibody overnight at 4°C, followed by incubation with Alexa Fluor® 647 goat anti-mouse IgG for one hour at room temperature. Nuclei were counterstained with DAPI, and the slides were mounted with ProLong™ Gold Antifade Mountant. The image was captured with a 20X objective. Scale Bar: 50 µm
  • A_SMI99_PURE_Myelin_IHCP_HuBrain20x_100418
    IHC staining of purified anti-Myelin Basic Protein antibody (clone SMI 99) on formalin-fixed paraffin-embedded human brain tissue. Following antigen retrieval using Retrieve-All Antigen Unmasking System 3: Acidic, 100X (Cat. No. 927601), the tissue was incubated with 0.25 µg/ml of the primary antibody overnight at 4°C, followed by incubation with Alexa Fluor® 647 goat anti-mouse IgG for one hour at room temperature. Nuclei were counterstained with DAPI, and the slides were mounted with ProLong™ Gold Antifade Mountant. The image was captured with a 20X objective. Scale Bar: 50 µm
  • B_SMI99_PURE_Myelin_IHCP_HuBrain10x_100418
    IHC staining of purified anti-Myelin Basic Protein antibody (clone SMI 99) on formalin-fixed paraffin-embedded human brain tissue. Following antigen retrieval using Retrieve-All Antigen Unmasking System 3: Acidic, 100X (Cat. No. 927601), the tissue was incubated with 0.25 µg/ml of the primary antibody overnight for 60 minutes at room temperature. BioLegend´s Ultra-Streptavidin (USA) HRP kit (Multi-Species, DAB, Cat. No. 929901) was used for detection followed by hematoxylin counterstaining, according to the protocol provided. The image was captured with a 10X objective. Scale bar: 50 µm
  • C_SMI99_PURE_Myelin_IHCP_MuBrain10x_100418
    IHC staining of purified anti-Myelin Basic Protein antibody (clone SMI 99) on formalin-fixed paraffin-embedded mouse brain tissue. Following antigen retrieval using Retrieve-All Antigen Unmasking System 3: Acidic, 100X (Cat. No. 927601), the tissue was incubated with 0.25 µg/ml of the primary antibody overnight at 4°C, followed by incubation with Alexa Fluor® 647 goat anti-mouse IgG for one hour at room temperature. Nuclei were counterstained with DAPI, and the slides were mounted with ProLong™ Gold Antifade Mountant. The image was captured with a 10X objective. Scale Bar: 50 µm
  • D_SMI99_PURE_Myelin_IHCP_MuBrain40x_100418
    IHC staining of purified anti-Myelin Basic Protein antibody (clone SMI 99) on formalin-fixed paraffin-embedded mouse brain tissue. Following antigen retrieval using Retrieve-All Antigen Unmasking System 3: Acidic, 100X (Cat. No. 927601), the tissue was incubated with 0.25 µg/ml of the primary antibody overnight for 60 minutes at room temperature. BioLegend´s Ultra-Streptavidin (USA) HRP kit (Multi-Species, DAB, Cat. No. 929901) was used for detection followed by hematoxylin counterstaining, according to the protocol provided. The image was captured with a 40X objective. Scale bar: 50 µm
  • E_SMI99_PURE_Myelin_IHCP_RatBrain40x_100418
    IHC staining of purified anti-Myelin Basic Protein antibody (clone SMI 99) on formalin-fixed paraffin-embedded rat brain tissue. Following antigen retrieval using Retrieve-All Antigen Unmasking System 3: Acidic, 100X (Cat. No. 927601), the tissue was incubated with 0.25 µg/ml of the primary antibody overnight at 4°C, followed by incubation with Alexa Fluor® 647 goat anti-mouse IgG for one hour at room temperature. Nuclei were counterstained with DAPI, and the slides were mounted with ProLong™ Gold Antifade Mountant. The image was captured with a 40X objective. Scale Bar: 50 µm
  • F_SMI99_PURE_Myelin_WB_10ugload_100418
    Western blot of purified anti-Myelin Basic Protein antibody (clone SMI 99). Lane 1: Molecular weight marker; Lane 2: 10 µg of human brain lysate; Lane 3: 10 µg of mouse brain lysate; Lane 4: 10 µg of rat brain lysate. The blot was incubated with 1 µg/mL of the primary antibody overnight at 4°C, followed by incubation with HRP labeled goat anti-mouse IgG (Cat. No. 405306). Enhanced chemiluminescence was used as the detection system.
Cat # Size Price Quantity Check Availability Save
808403 25 µL 90€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
808401 100 µL 221€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
808402 500 µL 400€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Myelin basic protein (MBP) is a protein involved in the myelination of nerves in the CNS. MBP functions to maintain the correct structure of myelin, through its interaction with the lipids in the myelin membrane. The myelin sheath is made up of MBP and lipids, and acts as an insulator to increase the velocity of axonal impulse conduction. MBP plays a central role in the demyelinating disease multiple sclerosis (MS). A hallmark of the disease is the loss of the myelin sheath surrounding nerves, thought to be induced by antibodies against MBP.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Human, Mouse, Rat
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution + 0.09% sodium azide.

Previous lots of this product may have been formulated with 0.1% or 0.05% NaN3 instead of 0.09% NaN3. For further information please contact BioLegend Technical Support or Customer Service.
Preparation
The antibody was purified by affinity chromatography.
Concentration
1 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C. Please note the storage condition for this antibody has been changed from -20°C to between 2°C and 8°C. You can also check your vial or your CoA to find the most accurate storage condition for this antibody.
Application

IHC-P - Quality tested
WB - Verified
ICC - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by formalin-fixed paraffin-embedded immunohistochemical staining. For immunohistochemistry, a concentration range of 0.25 – 0.5 µg/ml is suggested. For Western blotting, the suggested use of this reagent is 0.2 – 1.0 µg per ml. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

This antibody reacts with the sequence Ala-Ser-Asp-Tyr-Lys-Ser in position 131-136 of the classic human myelin basic protein. The antibody detects myelin basic protein from most mammalian species. This antibody detects developing and adult myelin, developing oligodedrocytes and distinguishes oligodendrocytes from astrocytes, microglia, neurons, and other cells in brain sections. The combination of this antibody with clone SMI-91 and/or SMI-94 is useful for immunocytochemical studies on the progression of normal and pathologic myelination.

Additional Product Notes

Myelin basic protein exists in multiple isoforms. By WB, clone SMI 99 detects mainly the 21 kD and 28 kD isoforms in the murine brain tissue, and the 21 kD isoform in the human brain tissue.

Application References
  1. Fyffe-Maricich SL, et al. 2011. J. Neurosci. 31(3):843-50. (IHC, WB) PubMed
  2. Mendz GL, et al. 1985. Biochem. 228(1):61-8.
  3. Kerlero De Rosbo N, et al. 1984. Neurochem. Res. 9(10):1359-69.
  4. Carnegie PR, et al. 1983. J. Neuroimmunol. 5(2):125-34.
  5. Dowse CA, et al. 1983. J. Neuroimmunol. 5(2):135-44.
  6. Del Valle L,et al. Cancer Biol Ther. 9:286. (IHC) PubMed
  7. Kiryu-Seo S, et al. 2010. J. Neurosci. 30(19):6658-66. (ICC) PubMed
  8. Samanta J, et al. 2010. Stroke. 41(2):357-62. (IHC) PubMed
  9. Werner HB, et al. 2007. J. Neurosci. 27(29):7717-30. (WB, ICC) PubMed
Product Citations
  1. Huang S, et al. 2021. STAR Protocols. 2(2):100416. PubMed
  2. Lee SH, et al. 2020. Ann Neurol. 88:526. PubMed
  3. Šimic G, et al. 2022. J Comp Neurol. 530:2711. PubMed
  4. Wang N, et al. 2022. Glia. 70:2093. PubMed
  5. Acheta J, et al. 2022. Glia. 70:2276. PubMed
  6. Yamanaka K, et al. 2023. Glia. 71:541. PubMed
  7. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  8. Xue W, et al. 2023. iScience. 26:105898. PubMed
  9. Weier A, et al. 2022. Int J Mol Sci. 23:. PubMed
  10. Clawson ED, et al. 2023. STAR Protoc. 4:102072. PubMed
  11. Elitt MS, et al. 2020. Nature. 585:397. PubMed
  12. Shi Y, et al. 2016. Mol Pain. 10.1177/1744806916656845. PubMed
  13. Ou Z et al. 2019. Cell reports. 26(11):2984-2997 . PubMed
  14. Rumajogee P, et al. 2019. Eneuro. 5. PubMed
  15. Ayanwuyi L, et al. 2022. Neural Regen Res. 17:1042. PubMed
  16. Sophie B, et al. 2019. Front Mol Neurosci. 12:177. PubMed
  17. Chew LJ, et al. 2020. Cell Reports. 29(10):3173-3186.e7.. PubMed
  18. Ma Q, et al. 2020. J Neuroinflammation. 0.914583333. PubMed
  19. Sherafat A, et al. 2021. Nat Commun. 12:2265. PubMed
  20. Fyffe-Maricich S, et al. 2011. J Neurosci. 31:843-850. PubMed
  21. Luo F, et al. 2016. J Neurosci. 36: 3024 - 3037. PubMed
  22. Della-Flora Nunes G, et al. 2021. Nat Commun. 12:3285. PubMed
  23. Tammia M, et al. 2018. Heliyon. 4:e00982. PubMed
  24. Hernandez M, et al. 2016. J Neurosci. 36: 806 - 813. PubMed
  25. Jeffries M, et al. 2016. J Neurosci. 36: 9186 - 9200. PubMed
  26. Choi K, et al. 2021. The FASEB Journal. 35(2):e21297. PubMed
  27. Liu J, et al. 2016. J Neurosci. 36: 957 - 962. PubMed
  28. Valle L, et al. 2010. Cancer Biol Ther. 9:286-294. PubMed
  29. Zotter B, et al. 2022. J Neurosci. 42:183. PubMed
  30. Keogh CE, et al. 2021. Brain Behav Immun. 91:437. PubMed
  31. Roth LM, et al. 2021. Glia. . PubMed
  32. Žunić Išasegi I, et al. 2018. Brain Struct Funct. 223:3919. PubMed
  33. Zhang Y, et al. 2019. Anim Cells Syst (Seoul). 1.222222222. PubMed
  34. Swartzlander DB, et al. 2018. JCI Insight. 3:. PubMed
  35. Ryu J, et al. 2021. Sci Rep. 11:8620. PubMed
  36. Safaiyan S, et al. 2016. Nat Neurosci. 10.1038/nn.4325. PubMed
  37. Yermakov LM et al. 2018. Frontiers in cellular neuroscience. 0.601388889 . PubMed
  38. Zhao Y, et al. 2018. Biochem Biophys Res Commun. 507:319. PubMed
  39. Orthmann-Murphy J, et al. 2020. eLife. 9:00. PubMed
  40. Huang S, et al. 2020. Cell Rep. 33:108394. PubMed
  41. Xin W, et al. 2019. Cell Rep. 27:2262. PubMed
  42. de Rosa V, et al. 2019. EMBO Mol Med. 11:. PubMed
  43. Ahn JH, et al. 2021. J Korean Med Sci. 36:e332. PubMed
  44. Werner H, et al. 2007. J Neurosci. 27:7717-7730. PubMed
  45. Battefeld A, Klooster J, Kole M 2016. Nat Commun. 7:11298. PubMed
  46. Reed CB, et al. 2020. J Neurosci. 40:6165. PubMed
  47. Zhang S, et al. 2021. The Journal of Neuroscience. 41(8):1650-1664. PubMed
  48. Wang Q, et al. 2020. Cell. 181(4):936-953. PubMed
  49. Chesnut M, et al. 2021. Int J Mol Sci. 22:. PubMed
  50. Bénardais K, et al. 2022. Brain Commun. 4:fcac025. PubMed
  51. Larson VA et al. 2018. eLife. 7 pii: e34829. PubMed
  52. Barron T et al. 2018. Scientific reports. 8(1):1022 . PubMed
  53. Ryu J, et al. 2022. Pharmaceutics. 14:. PubMed
  54. Zhang S, et al. 2020. The Journal of Neuroscience. 41(2):251-268. PubMed
  55. Keiichiro Susuki et al. 2018. The Journal of Neuroscience. 38(27):6063-6075 . PubMed
  56. Radecki DZ, et al. 2022. STAR Protoc. 3:101153. PubMed
  57. Philips T, et al. 2021. Cell Reports. 34(2):108610. PubMed
  58. Gail Canter R, et al. 2019. Commun Biol. 0.333333333. PubMed
  59. Teo W, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  60. Tian X, et al. 2020. J Pain. . PubMed
  61. Hanf KJM, et al. 2020. MAbs. 12:1713648. PubMed
  62. Acheta J, et al. 2022. Front Mol Neurosci. 15:881571. PubMed
  63. Jablonska B, et al. 2022. Nat Commun. 13:4771. PubMed
  64. Alam MM, et al. 2021. eneuro. 8(1):. PubMed
  65. Matson KJE, et al. 2022. Nat Commun. 13:5628. PubMed
  66. St Pierre M, et al. 2021. Dev Neurosci. 44:214. PubMed
  67. Roth LM, et al. 2021. Glia. 69:362. PubMed
  68. Gobbo D, et al. 2021. Front Neurol. 12:661408. PubMed
  69. Kiryu-Seo S, et al. 2010. J Neurosci. 30:6658-6666. PubMed
  70. Samanta J, et al. 2010. Stroke. 41:357-362. PubMed
  71. Allan KC, et al. 2020. Cell Stem Cell. 28(2):257-272.e11. PubMed
  72. Palma A, et al. 2022. Front Cell Dev Biol. 10:841548. PubMed
  73. Call CL, et al. 2021. Nature Communications. 12(1):4767. PubMed
RRID
AB_2564741 (BioLegend Cat. No. 808403)
AB_2564741 (BioLegend Cat. No. 808401)
AB_2564741 (BioLegend Cat. No. 808402)

Antigen Details

Cell Type
Oligodendrocytes
Biology Area
Cell Biology, Cell Structure, Neurodegeneration, Neuroinflammation, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules
Gene ID
4155 View all products for this Gene ID 17196 View all products for this Gene ID 24547 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
Myelin Basic Protein
Specificity Alt (DOES NOT SHOW ON TDS):
Myelin Basic Protein
App Abbreviation (DOES NOT SHOW ON TDS):
IHC-P,WB,ICC
UniProt
View information about Myelin Basic Protein on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 6    Revision Date: 02.08.2024

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account